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Proceedings
The Human in the Middle:
Artificial Intelligence in Health Care
Summary Proceedings
Symposium Presentation and Reactor Panel of Experts
Thomas Jefferson University
December 10, 2019
Janice Clarke, RN, BBA,1 Alexandria Skoufalos, EdD,1 and Stephen K. Klasko, MD, MBA2
Guest Editorial by Stephen K. Klasko, MD, MBA
Building Ethical and Sustainable Business Models
for the Use of AI and Machine Learning in Health
Care: Protecting the Human in the Middle
Artificial intelligence (AI) is evolving at warp speed,
and new applications enter the market daily. So much at-
tention is fixed on the promise of robotics and machine
learning that it’s easy to lose sight of the impact of new
technologies on the people they’re intended to serve. The
potential harms and benefits can be amplified when AI is
deployed in health care, and unintended consequences can
be life-altering.
For generations, science fiction writers have explored
scenarios in which machines and humans interact and battle
with one another while the fate of the world hangs in the
balance. But the books have not yet been written about the
kinds of advances we will soon see in machine thinking.
Consider the flurry of activity occurring daily across
health care’s academic, clinical, business, and entrepre-
neurial sectors: attention-based learning, neural networks,
online-meets-offline (OMO), the Internet of Things (IOT),
and the infamous ‘‘black box’’ where the machine writes its
own rules of engagement. How much consideration has been
given to the human in the middle of these myriad interac-
tions occurring online, offline, and in the cloud?
The purpose of AI in health care is to improve the
quality and efficiency of care delivered by clinicians, lower
the cost of that care, and provide support for clinical and
shared decision making. How much consideration is given
to the effect on the humans who program, depend on, and
query the technology? What is the impact of information
sharing between ‘‘Alexa’’ and Bluetooth-enabled devices
(FitBit, continuous glucose monitor, or other wearable)
that communicate with physicians, the health system, and
public payer electronic health records? How much data
should be shared? With whom? For what purpose? And for
how long?
Ethicist Aimee van Wynsberghe argues that the AI journey
must begin by initiating a meaningful conversation regarding
ethics that encompasses values. Responsible use of AI must
begin by establishing a climate of trust between the people
developing the technology and the people who will be using
or exposed to it. A product should be practical, useful, and
‘‘trustworthy’’ before it ever leaves the drawing board.
Computers will always be superior to humans when it
comes to storing and quickly processing information, but can
a machine ever ‘‘learn’’ self-awareness, cultural sensitivity,
and empathy – the uniquely human wisdom gained through
life experience? Humans have extraordinary abilities when it
comes to anticipating the unexpected and considering health-
related options in ways that align with their personal values.
How can we foster a collaborative culture and framework
that combines the unique qualities of technology and hu-
mans for achieving better population health?
We spent decades learning to mentor students in inter-
professional education. The next logical progression is a
vehicle to mediate the interactions between humans and AI:
a ‘‘Center for Inter-Sentient Education’’ that offers health
care professionals a thorough grounding in medical infor-
matics, robotics, and the ethical use of technology.
The ‘‘human in the middle’’ is the right frame for these
discussions. Design should focus on the needs and desires of
individuals/patients rather than institutions/corporations to
ensure these technologies do not just benefit the rich. It all
comes down to what kind of society we want for our chil-
dren and grandchildren.
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THE HUMAN IN THE MIDDLE: PRESENTATION
AND REACTOR PANEL PROCEEDINGS
Ideally, AI technology should facilitate the collaborative output of robots and hu-
mans to build a future of ‘‘health assurance,’’ whereby people are supported in their
ultimate goal of wellness. On December 10, 2019, Thomas Jefferson University in
Philadelphia, PA initiated an informative and enlightening dialogue on this important
topic.
Moderator:
Stephen K. Klasko, MD, MBA, President of Thomas Jefferson University and Chief Executive Officer of Jefferson
Health. A Distinguished Fellow of the World Economic Forum, Dr. Klasko is an advocate for transformation of health
care delivery and medical education.
Presenter:
Aimee van Wynsberghe, PhD, Assistant Professor of Robotics and Ethics, Delft University of Technology in the
Netherlands. Dr. Van Wynsberghe, one of Europe’s foremost robotics ethicists, presented the ethics standards for AI for
the European Commission as part of the High-Level Expert Group on AI. In 2020, she will present those standards to the
European Parliament.
Panelists:
Osagie Imasogie, LLM, Co-Founder and Senior Managing Partner, PIPV Capital. An acknowledged ‘‘serial entre-
preneur,’’ Imasogie has more than 30 years of experience in the fields of law, finance and business management, health
care, and the pharmaceutical industry.
Bon Ku, MD, MPP, Assistant Dean for Health and Design, Thomas Jefferson University. A practicing emergency
medicine physician, Dr. Ku directs the Health Design Lab and created the first design thinking program at a US medical
college.
Derek O’Halloran, MPA, Head of the World Economic Forum’s initiative on the future of the digital economy and
society.
Amanda Walker, third-year medical student, Sidney Kimmel Medical College. Walker instructs a humanities course
titled ‘‘Frontiers of Medical Ethics’’ for first-year medical students.
Left to right: Stephen K. Klasko, Amanda Walker, Derek O’Halloran, Osagie Imasogie, Bon Ku, and Aimee van Wynsberghe.
Photo courtesy of Thomas Jefferson University. Reproduced with permission.
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Presentation: A Medical Ethics Perspective
on Artificial Intelligence in Health Care
Ethicist Aimee van Wynsberghe made a persuasive ar-
gument that the journey must begin by initiating a mean-
ingful conversation regarding AI and ethics in the context of
health care – a conversation that encompasses values such as
data privacy, ownership and governance, access and equity,
virtual versus in-person therapy. Developing and using AI
technology in a responsible manner requires careful con-
sideration of downstream consequences.
Embedding ethics early in the design process assures that
a thorough assessment will be conducted regarding how a
product will be used, by whom, and under what conditions.
This process leads to better understanding of its value to
society and to consumers.
As applied in health care today, use of AI is essentially a
real-world experiment conducted without the consent of the
individuals it affects. When a product involves health and
well-being, there must be explicit acknowledgement of the
experimental nature, and simply stated terms and conditions
that describe how personal data will be collected, used, and
disclosed. There are many questions that require careful
consideration, including potential use of data for a purpose
unrelated to the original experiment, expected life cycle of
the data collected, and inherent bias in algorithms.
As we work to meet growing demands from health care
professionals and consumers, we must find efficient ways to
expand AI advances to meet the needs of historically un-
derserved populations in addition to those already accul-
turated to technology. The stakes are high in health care; a
medical ethicist on the design team can help uncover, un-
derstand, mediate and mitigate risks.
Dr. Van Wynsberghe characterized ethics as a call to action,
requiring us to assess our values and evaluate how we ensure,
protect, and aid the people in the middle. This is especially true
when we develop new products. She believes ethics is integral
to the product design process from its inception; in essence, the
heart of an ethical business model for AI in health care.
‘‘Ethics is the study of ‘the good life.’ We can define
it and create a path to achieving it; but it is an on-
going process, not a checklist. Starting with ethics, we
need to envision ’the good life’ we want to achieve.
What does that ’good life’ look like, and how do we
use AI to help us get there?’’ – Aimee van Wynsberghe
Panelist Reactions
Health Care Industry Business Perspective
Panelist Osagie Imasogie reasoned that meaningful con-
versation about ethics requires a mutually accepted defini-
tion of the term. What one considers as ethical depends on
the social and cultural context. AI programming should not
begin without taking into account the embedded logic tree
that will drive outputs.
We can learn from science fiction. Ironically, it addresses
the nuances of ethics and ethical dilemmas in a more
thoughtful way than actual science.
Health Economics Perspective
Panelist Derek O’Halloran of the World Economic Forum
argued that even the way data are collected becomes an
evaluation of our societal values. The cloud of data and
intelligence that AI is gathering can end up one of 2 ways. It
could help us design economic and societal systems that are
truly human-centric, or it could be used to create wealth for
a few, increasing exclusion and inequity.
Conversations about AI are not exclusive to health care,
but are happening in many sectors of the consumer space
and industry.
On a very basic level, we shape the future through small
decisions we make every day. At scale, the process becomes
one of adoption and acceptance. We must carefully consider
what we want in both economic and societal terms, em-
bedding ethics in all discussions.
The study of ethics in health care often focuses on pro-
tecting the patient’s rights. The ‘‘human in the middle’’ is
each individual in the middle of myriad things that happen
in their lives.
Medical Student Perspective
Panelist Amanda Walker views AI as a powerful tool
when complemented by conversation and joint decision
making with health care professionals.
†We have the technology to allow a 70-year-old
person to give birth to a child. Should we encourage
this? Is that the best option for the child or for soci-
ety? These are questions that we need to consider.†
– Amanda Walker
Thomas Jefferson University’s Sidney Kimmel Medical
College pioneered a medical education track that focuses on
the humanities in terms of what we should do with all the
information we have. Medical ethics, a required course for
medical students, helps students think through these ‘‘what
if’’ scenarios.
Computer Science and Technology
Design Perspective
As an increasing number of consumers make health
care decisions based on information that is available and
easily accessible online, clinicians must be prepared
to have conversations about that information with their
patients.
Panelist Bon Ku believes that design thinking begins
with empathy (ie, understanding the person who will use
the tool) and that successful product development incor-
porates an ‘‘intimate feedback loop’’ with that user. Re-
gardless of how exciting the technologies might be,
programmers should resist the temptation to work in iso-
lation and always include clinicians, patients, and care-
givers in product designs.
The electronic health record (EHR), a major AI devel-
opment in health care, has not lived up to its promise, in
large part because of a design flaw. EHR systems are costly
to implement and add a complexity burden to the human
workload. Many clinicians view the EHR as a barrier to
empathy with their patients.
‘‘When I encounter something I like or dislike when
working with an electronic health record in the emer-
gency room, I’d appreciate having an intimate feed-
back loop that allows a developer to make a change in
real time.’’ – Bon Ku
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Perspectives on Privacy
Moderator Stephen Klasko noted that, in the United
States, views on privacy tend to vary generationally and
socioeconomically. Trust is a huge factor. For example, when
free genomic testing was offered system-wide to all Jefferson
employees, willing acceptance was concentrated among em-
ployees at the lower end of the workforce pay scale. These
employees appreciated having access to information about
their health risk, whereas employees at the higher end were
more concerned about how the data would be used.
According to Dr. Van Wynsberghe, privacy is no longer a
big concern in Europe. The General Data Protection Reg-
ulation mandates that companies secure explicit permission
for tasks requiring data collection, and that they collect the
minimum amount of data for completing the task.
Mr. O’Halloran commented that large companies have
found ways to combine and share data and drive insights
without infringing on privacy rights. Many are doing this via
a series of rights and permissions regarding data pools rather
than seeking data ownership. He also observed that the most
successful start-ups and apps are those that are the most
privacy conscious.
Mr. Imasogie added that most people are not thinking
carefully about volunteering their personal data because
they focus on and have grown accustomed to the benefit
they derive from sharing it. Facebook is a prime example –
2.5 billion people who choose to use the app provide a huge
amount of data.
‘‘Why would someone give you a free service?
Because they will get the data. That is the deal. The
person is the product.and that is the ‘quid pro
quo’.’’ – Osagie Imasogie
Technology and Disparities
Dr. Klasko observed that technology has the potential to
increase or decrease disparities depending upon how we use
it. He asked panelists to consider policies that might help the
industry move toward a greater social good.
Dr. van Wynsberghe referred to the United Nations’
sustainable development goals, several of which incorporate
AI. In addition to creating awareness and a shared envi-
ronment to support collaboration, we must consider funding
instruments.
Ms. Walker pointed out the increasing importance of data
science training for medical students, who need to under-
stand the black box inputs (eg, whether the data are biased)
and how to evaluate data output.
According to Mr. O’Halloran, the next waves of inno-
vation will be at the business model level. Businesses face
challenges on 2 fronts: their core business models and their
roles in society. Successful models will be those that create
positive societal outcomes in addition to creating economic
value. Interconnectedness will make it possible to serve
markets that previously were inaccessible.
Mr. Imasogie believes that intellectual property (IP) is the
fundamental issue underlying disparities. ‘‘The net worth of
22 human beings now exceeds the net worth of 3.9 billion
people (half of the people on the planet) because they had
access to and have ownership of IP.’’ IP is the only asset
class that allows unlimited gains in wealth. We must rethink
the 20-year protection clause in our patent regulations.
Implications for Interprofessional Education
Academia has spent decades learning to mentor students
in interprofessional education. Dr. Klasko posited that the
time has come to support collaborative thinking between
humans and machines. An appreciation of †inter-sentient†
thinking could be revolutionary for academic health centers.
In a world of augmented intelligence, future education will
be oriented to teaching humans to be humans, not robots.
In 2020, most US medical schools continue to select
students based on their science grade point averages, or-
ganic chemistry grades, and scores on the standardized
Medical College Admissions Test. It should come as no
surprise that patients often describe their doctors as lacking
empathy, creativity, and good communication skills.
‘‘It’s incredibly difficult to deliver an unscheduled,
undiagnosed infant with Down syndrome. Inevitably,
the parents ask what this means. Good obstetricians
explain the chromosomal abnormalities; great obste-
tricians say, ‘This means you’ve delivered a beautiful
baby who will love you forever. We’ll introduce you to
other parents who have delivered beautiful babies like
yours.’ An artificial brain can’t help people understand
the meaning of some situations.’’ – Stephen Klasko
Conclusion
The challenge: To build ethical and sustainable business
models for the use of artificial intelligence and machine
learning in health care.
The premise: Technology can serve as a tool for re-
focusing US health care delivery from sick care to health
assurance (ie, offering both personalized paths to wellness
and customized care plans to manage chronic and complex
disease). Precision medicine models might be developed to
promote population health and reduce health inequities.
A graphic representation of the symposium is available as
online Supplemental Data.
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